New nerve block could ease pain after stomach surgery

NCT ID NCT07496086

Recruiting now Symptom relief Sponsor: General Hospital of Ningxia Medical University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new nerve block (EOIB) to a standard combination of blocks for pain after laparoscopic stomach removal. 100 adults undergoing this surgery will be randomly assigned to receive one of the two blocks. The goal is to see if the new block is as good at reducing pain and opioid use, and if it improves recovery quality.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nerve block procedure (external oblique intercostal block)
What this could lead to: If it works, this could offer a simpler, effective option for pain relief after stomach surgery, potentially reducing opioid use and improving recovery.
What could go wrong: This is a small, early-stage trial (100 people) comparing two nerve blocks, so results may not apply to everyone. The new block might not work as well as expected, and any nerve block carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE PAIN

Contacts and locations

Locations

General hospital of Ningxia medical university
RECRUITING

Yinchuan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.